Latest Technologic and Surgical Developments in Using InterStim™ Therapy for Sacral Neuromodulation: Impact on Treatment Success and Safety

European Urology

Volumn 54, Issue 6, 2008, Pages 1287-1296

  Spinelli, Michele ^a   Sievert, Karl Dietrich ^b  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Efficacy; Electrode; Quality of life; Sacral neuromodulation; Safety; Therapy; Tined lead; Urinary dysfunction

Indexed keywords

BOTULINUM TOXIN A; LEAD;

ARTICLE; CONSERVATIVE TREATMENT; DETRUSOR DYSSYNERGIA; HUMAN; IMPLANT; INTERMETHOD COMPARISON; MINIMALLY INVASIVE SURGERY; NEUROMODULATION; OVERACTIVE BLADDER; POSTVOID RESIDUAL URINE VOLUME; PRIORITY JOURNAL; QUALITY OF LIFE; REPEATED DRUG DOSE; SACRAL NEUROMODULATION; SAFETY; SIDE EFFECT; URINARY DYSFUNCTION; URINARY TRACT INFECTION; URINE INCONTINENCE; URINE RETENTION;

EQUIPMENT DESIGN; HUMANS; PROSTHESIS IMPLANTATION; QUALITY OF LIFE; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION; URINATION DISORDERS; VIDEODISC RECORDING;

EID: 55649094894     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.01.076     Document Type: Article

References (38)

1. Wein A.J., and Rackley R.R. Overactive bladder: a better understanding of pathophysiology, diagnosis and management. J Urol 175 (2006) S5-S10
2. Fitzpatrick J.M., and Kirby R.S. Management of acute urinary retention. BJU Int 97 suppl 2 (2006) 16-20
3. Schmidt R.A., Bruschini H., and Tanagho E.A. Sacral root stimulation in controlled micturition. Peripheral somatic neurotomy and stimulated voiding. Invest Urol 17 (1979) 130-134
4. Schmidt R.A., Jonas U., Oleson K.A., et al. Sacral nerve stimulation for treatment of refractory urinary urge incontinence. Sacral Nerve Stimulation Study Group. J Urol 162 (1999) 352-357
5. Leng W.W., and Chancellor M.B. How sacral nerve stimulation neuromodulation works. Urol Clin North Am 32 (2005) 11-18
6. van Voskuilen A.C., Oerlemans D.J., Weil E.H., de Bie R.A., and van Kerrebroeck P.E. Long term results of neuromodulation by sacral nerve stimulation for lower urinary tract symptoms: a retrospective single center study. Eur Urol 49 (2006) 366-372
7. Janknegt R.A., Weil E.H., and Eerdmans P.H. Improving neuromodulation technique for refractory voiding dysfunctions: two-stage implant. Urology 49 (1997) 358-362
8. Kessler T.M., Madersbacher H., and Kiss G. Prolonged sacral neuromodulation testing using permanent leads: a more reliable patient selection method?. Eur Urol 47 (2005) 660-665
9. Pannek J., Grigoleit U., and Hinkel A. Bacterial contamination of test stimulation leads during percutaneous nerve stimulation. Urology 65 (2005) 1096-1098
10. Borawski K.M., Foster R.T., Webster G.D., and Amundsen C.L. Predicting implantation with a neuromodulator using two different test stimulation techniques: a prospective randomized study in urge incontinent women. Neurourol Urodyn 26 (2007) 14-18
11. Peters K.M., Carey J.M., and Konstandt D.B. Sacral neuromodulation for the treatment of refractory interstitial cystitis: outcomes based on technique. Int Urogynecol J Pelvic Floor Dysfunct 14 (2003) 223-228
12. Kessler T.M., Buchser E., Meyer S., et al. Sacral neuromodulation for refractory lower urinary tract dysfunction: results of a nationwide registry in Switzerland. Eur Urol 51 (2007) 1357-1363
13. Everaert K., Kerckhaert W., Caluwaerts H., et al. A prospective randomized trial comparing the 1-stage with the 2-stage implantation of a pulse generator in patients with pelvic floor dysfunction selected for sacral nerve stimulation. Eur Urol 45 (2004) 649-654
14. Sievert K.D., Nagele U., Pannek J., et al. Subcutaneous tunneling of the temporary testing electrode significantly improves the success rate of subchronic sacral nerve modulation (SNM). World J Urol 25 (2007) 607-612
15. Spinelli M., Giardiello G., Arduini A., and van den Hombergh U. New percutaneous technique of sacral nerve stimulation has high initial success rate: preliminary results. Eur Urol 43 (2003) 70-74
16. Spinelli M., Giardiello G., Gerber M., et al. New sacral neuromodulation lead for percutaneous implantation using local anesthesia: description and first experience. J Urol 170 (2003) 1905-1907
17. Cohen B.L., Tunuguntla H.S., and Gousse A. Predictors of success for first stage neuromodulation: motor versus sensory response. J Urol 175 (2006) 2178-2181
18. Spinelli M., Weil E., Ostardo E., et al. New tined lead electrode in sacral neuromodulation: experience from a multicentre European study. World J Urol 23 (2005) 225-229
19. Deng D.Y., Gulati M., Rutman M., Raz S., and Rodríguez L.V. Failure of sacral nerve stimulation due to migration of tined lead. J Urol 175 (2006) 2182-2185
20. Scheepens W.A., Weil E.H., van Koeveringe G.A., et al. Buttock placement of the implantable pulse generator: a new implantation technique for sacral neuromodulation-a multicenter study. Eur Urol 40 (2001) 434-438
21. Starkman J.S., Wolter C.E., Scarpero H.M., Milam D.F., and Dmochowski R.R. Management of refractory urinary urge incontinence following urogynecological surgery with sacral neuromodulation. Neurourol Urodyn 26 (2007) 29-35
22. van Voskuilen A.C., Oerlemans D.J., Weil E.H., van den Hombergh U., and Van Kerrebroeck P.E. Medium-term experience of sacral neuromodulation by tined lead implantation. BJU Int 99 (2007) 107-110
23. Siegel S.W., Catanzaro F., Dijkema H.E., et al. Long-term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency-frequency, and retention. Urology 56 suppl 6A (2000) 87-91
24. Amundsen C.L., Romero A.A., Jamison M.G., and Webster G.D. Sacral neuromodulation for intractable urge incontinence: are there factors associated with cure?. Urology 66 (2005) 746-750
25. Sherman N.D., Jamison M.G., Webster G.D., and Amundsen C.L. Sacral neuromodulation for the treatment of refractory urinary urge incontinence after stress incontinence surgery. Am J Obstet Gynecol 193 (2005) 2083-2087
26. South M.M.T., Romero A.A., Jamison M.G., Webster G.D., and Amundsen C.L. Detrusor overactivity does not predict outcome of sacral neuromodulation test stimulation. Int Urogynecol J Pelvic Floor Dysfunct 18 (2007) 1395-1398
27. Goh M., and Diokno A.C. Sacral neuromodulation for nonobstructive urinary retention-is success predictable?. J Urol 178 (2007) 197-199
28. Foster Sr. R.T., Anoia E.J., Webster G.D., and Amundsen C.L. In patients undergoing neuromodulation for intractable urge incontinence a reduction in 24-hr pad weight after the initial test stimulation best predicts long-term patient satisfaction. Neurourol Urodyn 26 (2007) 213-217
29. Kessler T.M., Madersbacher H., and Kiss G. Bilateral migration of sacral neuromodulation tined leads in a thin patient. J Urol 173 (2005) 153-154
30. Hijaz A., Vasavada S.P., Daneshgari F., et al. Complications and troubleshooting of two-stage sacral neuromodulation therapy: a single-institution experience. Urology 68 (2006) 533-537
31. Sutherland S.E., Lavers A., Carlson A., et al. Sacral nerve stimulation for voiding dysfunction: one institution's 11-year experience. Neurourol Urodyn 26 (2007) 19-28
32. ®: Ergebnisse einer Anwenderbefragung zu aktuellen technischen Entwicklungen. J Urol Urogynäkol 14 (2007) 14-16
33. Latini J.M., Alipour M., and Kreder Jr. K.J. Efficacy of sacral neuromodulation for symptomatic treatment of refractory urinary urge incontinence. Urology 67 (2006) 550-554
34. Schmid D.M., Sauermann P., Werner M., et al. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics. J Urol 176 (2006) 177-185
35. Sahai A., Khan M.S., Dasgupta P., and The GKT Botulinum Study Group. Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial. J Urol 177 (2007) 2231-2236
36. Ghalayini I.F., and Al-Ghazo M.A. Intradetrusor injection of botulinum-A toxin in patients with idiopathic and neurogenic detrusor overactivity: urodynamic outcome and patient satisfaction. Neurourol Urodyn 26 (2007) 531-536
37. Rajkumar G.N., Small D.R., Mustafa A.W., and Conn G. A prospective study to evaluate the safety, tolerability, efficacy and durability of response of intravesical injection of botulinum toxin type A into detrusor muscle in patients with refractory idiopathic detrusor overactivity. BJU Int 96 (2005) 848-852
38. Kessler T.M., Danuser H., Schumacher M., Studer U.E., and Burkhard F.C. Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity?. Neurourol Urodyn 24 (2005) 231-236